Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.
Company profile
Ticker
GNMX
Exchange
Website
CEO
Michael F. Cola
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Aevi Genomic Medicine, Inc., Medgenics Inc, Medgenics, Inc.
SEC CIK
Corporate docs
IRS number
980217544
GNMX stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
14 Feb 20
EFFECT
Notice of effectiveness
14 Feb 20
EFFECT
Notice of effectiveness
14 Feb 20
EFFECT
Notice of effectiveness
14 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 20
Latest ownership filings
4
MICHAEL F COLA
11 Jun 20
SC 13G/A
Aevi Genomic Medicine, LLC
14 Feb 20
SC 13G/A
Beneficial ownership report (amended)
12 Feb 20
4
Change in insider ownership
7 Feb 20
3
Initial statement of insider ownership
7 Feb 20
SC 13D
Beneficial ownership report
7 Feb 20
4
SOL J BARER
5 Feb 20
4
Michael McInaw
5 Feb 20
4
Barbara Gayle Duncan
5 Feb 20
4
Matthew D Bayley
5 Feb 20
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|